Kennedy, N. A., Goodhand, J., Bewshea, C., Nice, R., Chee, D., Lin, S., Chanchlani, N., Butterworth, J., Cooney, R., Croft, N., Hart, A., Irving, P., Kok, K., Lamb, C., Limdi, J., MacDonald, J., McGovern, D., Mehta, S., Murray, C., Patel, K., Pollok, R., Raine, T., Russell, R., Selinger, C., Smith, P., Bowden, J., McDonald, T., Lees, C., Sebastian, S., Powell, N., & Ahmad, T. (n.d.). oP03 Anti-SARS-CoV2 antibody responses are attenuated in patients with Inflammatory Bowel Disease treated with infliximab. Journal of Crohn's and colitis, 15, S002–S004. http://access.bl.uk/ark:/81055/vdc_100130765717.0x00000c